What Mediphacos does

Mediphacos Indústrias Médicas S/A is a Brazilian ophthalmic medical device company headquartered in Belo Horizonte, Minas Gerais, founded in 1972 and operating across 60+ countries on five continents with 101-250 employees. The company designs, manufactures, and distributes a vertically integrated portfolio spanning four product categories: cataract surgery (intraocular lenses including BIOS trifocal, UnA, Mediflex, MFR2, and Miniflex, plus surgical accessories and phaco equipment), specialty contact lenses for keratoconus and irregular corneas (Rose K2, Esclera, Esclera SG, KTA, Millennium XC, Optimum XC with Hydra-Peg coating), corneal treatment products (Keraring intracorneal ring segments with 25+ years of clinical history, surgical instruments, and Coronet vacuum trephines), and phakic IOLs (Intralens for high myopia correction). All products are manufactured in Brazil under ISO 13485:2016, ANVISA BPF, CE Mark (Keraring), and GMP Korea (Keraring) certifications.

The company operates a sales-led, B2B distribution model exclusively through specialist ophthalmologists and eye clinics, with products fitted or implanted by physicians rather than sold direct-to-consumer, supplemented by a Brazil-focused Vision Care online store and WhatsApp Help Desk for technical support. Mediphacos monetizes through one-time sales of medical devices and consumables, with clinical decision-making supported by proprietary surgical planning tools (Keraring Planner app on iOS/Android/Web) and Keraring nomogram calculators. Key technology differentiators include Rose K2's aspheric multicurve geometry for keratoconus, Keraring's multiple optical zone and thickness profiles, Coronet's 10x precision improvement over traditional trephines, and Intralens phakic IOL with central hole design and ErgoTouch injector. The company's competitive positioning rests on a 50-year track record, regulatory-certified Brazilian manufacturing, exclusive specialist channel relationships, and supporting digital tools rather than AI-driven capabilities.

Name

Mediphacos

Legal name

Mediphacos Indústrias Médicas S/A

Website

https://mediphacos.com

Company type

Private

Founded year

1972

Operating status

Operating

Headcount range

101–250 employees

Short description

Mediphacos is a Brazilian ophthalmic medical device company (founded 1972) that designs, manufactures, and distributes intraocular lenses, specialty contact lenses, intracorneal ring segments, and surgical instruments to specialist ophthalmologists in 60+ countries.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)

akta.pro secondary industries

Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE), Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF)

Keywords

• Ophthalmic medical devices
• Intraocular lenses
• Specialty contact lenses
• Keratoconus treatment
• Cataract surgery products

Headquarters

HQ city

Belo Horizonte

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Ophthalmic Medical Devices and Contact Lenses: Mediphacos generates revenue through the manufacture and sale of a comprehensive portfolio of ophthalmic products including gas permeable contact lenses, intraocular lenses, intracorneal ring segments, corneal trephine systems, and surgical instruments. Products are sold directly to ophthalmologists and eye clinics, with a B2B business model targeting eye care professionals exclusively.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Mediphacos researches, develops, manufactures, and distributes a comprehensive portfolio of ophthalmic medical devices including intraocular lenses (BIOS, UnA, Mediflex, MFR2, Miniflex, Intralens), specialty gas-permeable contact lenses (Esclera, Esclera SG, KTA, Millennium XC, Optimum XC, Rose K2), intracorneal ring segments (Keraring), corneal trephine systems (Coronet), and surgical instruments. Products are sold exclusively through ophthalmologist specialists and eye care clinics in over 60 countries across five continents, supported by proprietary surgical planning tools (Keraring Planner app and nomograms).

Product overview

Mediphacos is a Brazilian ophthalmology company offering a unified portfolio of medical devices for eye care, operating across four main product categories: Catarata (cataract surgery - including intraocular lenses BIOS, UnA, Mediflex, MFR2, Miniflex, and accessories), Vision Care (specialty contact lenses including Esclera, Esclera SG, KTA, Millennium XC, Optimum XC, Rose K2 with Hydra-Peg coating), Córnea (corneal products including Keraring intrastromal rings, surgical instruments, and Coronet trephines), and LIO Fácica (phakic intraocular lens - Intralens). The portfolio is complemented by software tools including the Keraring Planner app for surgical planning and the Keraring nomogram calculator. All products are manufactured in Brazil under ISO 13485-2016, CE Mark (Keraring), GMP Korea (Keraring), and ANVISA BPF certifications, with international presence in over 60 countries.

Differentiator

Problem solved

Functional benefit

Products and services

• BIOS Trifocal intraocular lens for cataract surgery, designed for ease of implantation, manipulation in the capsular sac, and excellent stability. Sold to ophthalmic surgeons.
• UnA Harmonic nature-based intraocular lens for cataract treatment, offering visual harmony with the eye's natural structure.
• Mediflex Intraocular lens for cataract surgery.
• MFR2 Intraocular lens for cataract surgery.
• Miniflex Intraocular lens for cataract surgery.
• Intralens Posterior chamber phakic intraocular lens for high myopia correction (-6D to -25D) in patients aged 21-45, featuring hydrophilic material, central hole, advanced optical and haptic design, and simplified usability with ErgoTouch injector.
• Esclera Gas-permeable scleral contact lens for irregular corneas, keratoconus, and dry eye patients, offering high oxygen permeability and superior comfort by resting on the less sensitive sclera.
• Esclera SG Advanced version of Esclera scleral lens with improved characteristics for keratoconus and irregular cornea adaptation, becoming an important option for progressive keratoconus adaptations.
• KTA (Keratoconus Technology Algorithm) Gas-permeable lens especially developed for keratoconus patients using Keratoconus Technology Algorithm, offering easy and efficient adaptation from early stages to advanced cases.
• Millennium XC Multifocal gas-permeable contact lens for presbyopia correction, particularly beneficial for high ammetropes and astigmats, featuring advanced optical design.
• Optimum XC Large-diameter gas-permeable contact lens for regular corneas made with high oxygen permeability Fluor Silicone Acrylate material (DK 125), designed for myopia, hyperopia, and astigmatism correction with extreme comfort and HD vision.
• Rose K2 World's most prescribed keratoconus contact lens with aspheric multicurve design and complex geometry allowing personalized approach for each corneal shape, correcting irregular myopia and astigmatism associated with keratoconus while maximizing corneal oxygenation (DK 100 - Boston XO). Includes variants Rose K2 NC, IC, XL, and PG.
• Keraring Corneal intrastromal ring segments for treatment of keratoconus and irregular ectatic corneas, with over 25 years of clinical use worldwide. Available in multiple configurations (S15, AS5, S16, AS6) with various arc lengths and thickness profiles. CE marked product.
• Coronet Vacuum trephine line for corneal transplants with blades 10 times more precise than traditional trephines. Includes Donor Punch (51-850) and Vacuum Receiver Trephine (51-840).
• Keraring Surgical Instruments High-precision titanium surgical instruments for each step of Keraring implantation surgery, including dissectors, suction rings, markers, forceps, and sterilization cases. Compatible with both manual dissection and femtosecond laser techniques.

Quantifiable outcome

• Cuts up to 10 times more precise than traditional trephines with Coronet system
• +3 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Menicon: Menicon is a global leader in gas-permeable and specialty contact lenses, including keratoconus and orthokeratology designs. Directly comparable to Mediphacos' Rose K2, Esclera, KTA, and Optimum XC specialty lens portfolio.
• Ophtec: Ophtec produces Artisan and Artiflex phakic IOLs and other ophthalmic implants, directly competing with Mediphacos' Intralens phakic IOL line in the refractive surgery space. Both serve specialist cataract and refractive surgeons globally.
• STAAR Surgical: STAAR Surgical is the leading manufacturer of phakic IOLs (Visian ICL), directly competing with Mediphacos' Intralens in the high-myopia refractive segment. Both target specialist ophthalmologists with posterior chamber phakic IOLs for patients unsuitable for LASIK.

Broad incumbents

• Alcon: Alcon is the world's largest eye-care device company, offering premium IOLs (PanOptix), surgical equipment, and contact lens care. Competes with Mediphacos across cataract, vision care, and surgical categories with much larger R&D and commercial resources.
• Bausch + Lomb: Bausch + Lomb is a global ophthalmic incumbent with broad IOL, contact lens, and surgical portfolios. Overlaps with Mediphacos across cataract IOLs, specialty GP lenses, and surgical instruments, but operates at significantly greater scale.
• Carl Zeiss Meditec: Carl Zeiss Meditec provides surgical ophthalmic microscopes, IOLs (CT LUCIA, CT SPHERIS), and consumables. Overlaps with Mediphacos in cataract surgery systems and IOLs as a premium-tier global incumbent.
• Hoya Corporation: Hoya's Surgical Optics division manufactures intraocular lenses (iSert, Vivinex) used in cataract surgery, directly competing with Mediphacos' IOL portfolio. A larger Japanese-based incumbent with global distribution.
• Johnson & Johnson Vision: J&J Vision offers the TECNIS IOL platform and ACUVUE contact lens franchise, broadly competing with Mediphacos in cataract and vision care categories. A larger incumbent with global scale and significant surgeon relationships.
• CooperVision: CooperVision is a major global contact lens manufacturer with broad GP, soft, and specialty lens lines. Overlaps with Mediphacos in specialty contact lenses but operates at much greater scale across consumer and professional channels.

Emerging players

• SynergEyes: SynergEyes specializes in hybrid and specialty contact lenses for keratoconus and irregular corneas, directly competing with Mediphacos' Rose K2 and Esclera lines. A smaller, focused player in the same specialty lens niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/mediphacos
• YouTubeyoutube.com/@mediphacos
• Facebookfacebook.com/Mediphacos
• LinkedInlinkedin.com/company/mediphacos
• Instagraminstagram.com/mediphacos

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mediphacos